These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35281758)

  • 21. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
    Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.
    Gómez-Otero I; Ferrero-Gregori A; Varela Román A; Seijas Amigo J; Pascual-Figal DA; Delgado Jiménez J; Álvarez-García J; Fernández-Avilés F; Worner Diz F; Alonso-Pulpón L; Cinca J; Gónzalez-Juanatey JR;
    Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):338-346. PubMed ID: 28011188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.
    Yaku H; Kato T; Morimoto T; Inuzuka Y; Tamaki Y; Ozasa N; Yamamoto E; Yoshikawa Y; Kitai T; Taniguchi R; Iguchi M; Kato M; Takahashi M; Jinnai T; Ikeda T; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Seko Y; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Shizuta S; Ono K; Sato Y; Kuwahara K; Kimura T;
    JAMA Netw Open; 2019 Jun; 2(6):e195892. PubMed ID: 31225889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study.
    Savarese G; Dahlström U; Vasko P; Pitt B; Lund LH
    Eur Heart J; 2018 Dec; 39(48):4257-4265. PubMed ID: 30351407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics of heart failure with recovered ejection fraction].
    Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of circulatory leukocyte based indices in short-term mortality of patients with heart failure with reduced ejection fraction.
    Sadeghi MT; Esgandarian I; Nouri-Vaskeh M; Golmohammadi A; Rahvar N; Teimourizad A
    Med Pharm Rep; 2020 Oct; 93(4):351-356. PubMed ID: 33225260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Use of Long-Acting Nitrates and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Lim SL; Benson L; Dahlström U; Lam CS; Lund LH
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28377439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of Neutrophil to Lymphocyte Ratio and Its Trajectory in Patients Hospitalized With Acute Heart Failure and Preserved Ejection Fraction.
    Boralkar KA; Kobayashi Y; Amsallem M; Ataam JA; Moneghetti KJ; Cauwenberghs N; Horne BD; Knowlton KU; Maecker H; Kuznetsova T; Heidenreich PA; Haddad F
    Am J Cardiol; 2020 Jan; 125(2):229-235. PubMed ID: 31753313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis.
    Lucijanic M; Krecak I; Soric E; Sabljic A; Galusic D; Holik H; Perisa V; Moric Peric M; Zekanovic I; Budimir J; Kusec R
    Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high absolute lymphocyte count predicts a poor prognosis in HER-2- positive breast cancer patients treated with trastuzumab.
    Hong J; Chen X; Gao W; Zhu S; Wu J; Huang O; He J; Zhu L; Chen W; Li Y; Fei X; Lin L; Shen K
    Cancer Manag Res; 2019; 11():3371-3379. PubMed ID: 31114373
    [No Abstract]   [Full Text] [Related]  

  • 39. Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.
    Araki K; Ito Y; Fukada I; Kobayashi K; Miyagawa Y; Imamura M; Kira A; Takatsuka Y; Egawa C; Suwa H; Ohno S; Miyoshi Y
    BMC Cancer; 2018 Oct; 18(1):982. PubMed ID: 30326862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent Acute Decompensated Heart Failure Admissions for Patients With Reduced Versus Preserved Ejection Fraction (from the Atherosclerosis Risk in Communities Study).
    Caughey MC; Sueta CA; Stearns SC; Shah AM; Rosamond WD; Chang PP
    Am J Cardiol; 2018 Jul; 122(1):108-114. PubMed ID: 29703442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.